A mathematical model to investigate drug targets for dupilumab poor responders in atopic dermatitis

被引：0
|
作者：
Miyano, T. [1 ]
Irvine, A. D. [2 ,3 ]
Tanaka, R. J. [1 ]
机构：
[1] Imperial Coll London, London, England
[2] Trinity Coll Dublin, Med Clin, Dublin, Ireland
[3] Childrens Hlth Ireland, Pediat Dermatol, Dublin, Ireland
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 187卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P61
引用
下载
收藏
页码：E39 / E40
页数：2
相关论文
共 50 条
  • [21] Drug Survival, Retention, and Persistence of Dupilumab in Adults and Adolescents with Atopic Dermatitis: A Narrative Literature Review
    Mariateresa Rossi
    Silvia M. Ferrucci
    Piergiacomo Calzavara-Pinton
    Angelo V. Marzano
    Ketty Peris
    Elena Nicoli
    Devis Moretti
    Andrea Chiricozzi
    Advances in Therapy, 2025, 42 (1) : 94 - 105
  • [22] Exploring novel drug targets for atopic dermatitis through plasma proteome with genome
    Wu, Wenhua
    Su, Hao
    Chen, Zhengrui
    Wei, Shanshan
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 2024, 316 (08)
  • [23] Drug survival of dupilumab treatment in atopic dermatitis: A real-life observation study in a clinical context
    Blasini, A.
    Eyerich, K.
    Biedermann, T.
    Darsow, U.
    Eberlein, B.
    ALLERGY, 2021, 76 : 219 - 219
  • [24] Clinical effectiveness of combined dupilumab and baricitinib in a patient with multi-drug resistant severe atopic dermatitis
    Lugli, Anna Paola
    Gori, Niccolo
    Chiricozzi, Andrea
    Boschetti, Giambattista
    Peris, Ketty
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024,
  • [25] A phase III study to investigate the efficacy and safety of abrocitinib and dupilumab in comparison with placebo in adults with moderate-to-severe atopic dermatitis
    Thaci, D.
    Bieber, T.
    Simpson, E. L.
    Silverberg, J. I.
    Paul, C.
    Sinclair, R.
    Pink, A. E.
    Kataoka, Y.
    Chu, C. -Y.
    DiBonaventura, M.
    Rojo, R.
    Antinew, J.
    Ionita, I.
    Forman, S.
    Zdybski, J.
    Biswas, P.
    Malhotra, B.
    Zhang, F.
    Valdez, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : E72 - E73
  • [26] Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis
    Kato, Aika
    Kamata, Masahiro
    Ito, Makoto
    Uchida, Hideaki
    Nagata, Mayumi
    Fukaya, Saki
    Hayashi, Kotaro
    Fukuyasu, Atsuko
    Tanaka, Takamitsu
    Ishikawa, Takeko
    Ohnishi, Takamitsu
    Tada, Yayoi
    JOURNAL OF DERMATOLOGY, 2020, 47 (09): : 1013 - 1019
  • [27] Atopic dermatitis: A relevant model to investigate the therapeutic potential of multi-lamellar liposomes
    Bernasque, A.
    Faure, C.
    Lecomte, S.
    Krisa, S.
    Cario, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (05) : S269 - S269
  • [28] Effectiveness, safety and drug survival of dupilumab in patients with moderate to severe atopic dermatitis: an interim analysis of the TREATgermany registry
    Stoelzl, D.
    Boraczynski, N.
    Heratizadeh, A.
    Haufe, E.
    Harder, I.
    Abraham, S.
    Heinrich, L.
    Kleinheinz, A.
    Wollenberg, A.
    Weisshaar, E.
    Schaekel, K.
    Ertner, K.
    Wiemers, F.
    Wildberger, J.
    Worm, M.
    von Kiedrowski, R.
    Effendy, I.
    Asmussen, A.
    Augustin, M.
    Pawlak, M.
    Sticherling, M.
    Zink, A.
    Hilgers, M.
    Handrick, C.
    Quist, S.
    Schwarz, B.
    Staubach-Renz, P.
    Bell, M.
    Hong-Weldemann, S.
    Homey, B.
    Bruecher, J.
    Schmitt, J.
    Werfel, T.
    Weidinger, S.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 (02) : E39 - E40
  • [29] BURDEN OF ATOPIC DERMATITIS IN INDONESIA, MALAYSIA, AND SINGAPORE: ESTIMATES FROM A MATHEMATICAL MODEL
    Bhanegaonkar, A.
    Horodniceanu, E. G.
    Ji, X.
    Detzel, P.
    Botteman, M. F.
    VALUE IN HEALTH, 2014, 17 (07) : A778 - A778
  • [30] Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab
    Davis, John D.
    Bansal, Ashish
    Hassman, David
    Akinlade, Bolanle
    Li, Meng
    Li, Zhaoyang
    Swanson, Brian
    Hamilton, Jennifer D.
    DiCioccio, A. Thomas
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (06) : 1146 - 1154
12345